Dr. Roger Rosenberg marks major milestone in field of neurology

Dr. Roger Rosenberg, Professor of Neurology and Neurotherapeutics and Physiology at UT Southwestern Medical Center, attended his 50th Annual meeting of the American Academy of Neurology (AAN) in April of this year. Dr. Rosenberg served as President of the AAN from 1991-1993 and has held many leadership roles in neurology, both nationally and at UT Southwestern Medical Center.

Dr. Rosenberg AAN Meeting 1992
1992 American Academy of Neurology (AAN) annual meeting in San Diego. From l-r: Stanley Prusiner, Nobel Laureate 1997 for Prion Diseases; Dr. Roger Rosenberg; Francis Crick, Nobel Laureate, 1962, co-discoverer of the double helical structure of DNA with James Watson; and William Oldendorf, who developed the mathematics for CT scanning. © 1992 American Academy of Neurology. Reproduced with permission.

The AAN Board of Directors invited Dr. Roger Rosenberg to be interviewed during the 2016 Annual Meeting as part of the AAN History of Neurology Series. The series provides insights and comments from AAN members who have been involved in leadership positions with the AAN and in American neurology.

Dr. Rosenberg being interviewed 240px by 160px
Dr. Rosenberg being interviewed by Lauren Klaffke, University of Minnesota, at the 2016 AAN meeting in Vancouver, BC, Canada. He discussed scientific achievements in neurology over the past 50 years and made predictions of future changes. © 2016 American Academy of Neurology. Reproduced with permission.

Dr. Rosenberg’s other leadership roles include: past First Vice-President of American Neurological Association (1986); Editor-in-Chief of JAMA Neurology for 20 years; former Chair of Neurology at UT Southwestern (1973-91); Principal Investigator of the NIH-Funded Alzheimer’s Disease Center at UT Southwestern (1988 to 2016); and Senior Editor of “Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease,” 5th Edition(2015).

As President of the AAN, he developed the original concept and implemented plans for developing the AAN Foundation to provide fellowship and research funding for junior members which has evolved into the present American Brain Foundation sponsored by the AAN.

Dr. Rosenberg’s major scientific interest is development of a DNA Aβ42 vaccine to prevent Alzheimer’s Disease. He has spent the past 30 years in research in neurodegenerative diseases and Alzheimer’s disease, in particular.

Dr. Rosenberg holds the Abe (Brunky), Morris and William Zale Distinguished Chair in Neurology and Neurotherapeutics.